Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease

被引：66
|
作者：
Parsa, MA [1 ]
Bastani, B [1 ]
机构：
[1] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA
来源：
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 1998年 / 10卷 / 02期
关键词：
D O I：
10.1176/jnp.10.2.216
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Psychoses are a common clinical problem in patients with Parkinson's disease. Treatment with typical neuroleptics or withdrawal of antiparkinsonian drugs may improve mental symptoms but will worsen the parkinsonism. Quetiapine (Seroquel), ICI 204,636, is a novel antipsychotic medication with a low potential for producing extrapyramidal side effects. In this open-label clinical study of 2 patients with Parkinson's disease, treatment with Seroquel successfully controlled psychotic symptoms without worsening of motor disability.
引用
收藏
页码：216 / 219
页数：4
相关论文
共 50 条
  • [21] TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA
    Ballard, Clive
    Mills, R.
    Williams, H.
    Corbett, A.
    Cummings, J.
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 : S2 - S2
  • [22] Dopaminomimetic psychosis in Parkinson's disease patients - Diagnosis and treatment
    Wolters, EC
    [J]. NEUROLOGY, 1999, 52 (07) : S10 - S13
  • [23] Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia
    Marsh, L
    Lyketsos, C
    Reich, SG
    [J]. PSYCHOSOMATICS, 2001, 42 (06) : 477 - 481
  • [24] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Friedman, J
    [J]. NEUROLOGY, 1998, 50 (04) : 1195 - 1196
  • [25] Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
    Wolters, EC
    Jansen, ENH
    TuynmanQua, HG
    Bergmans, PLM
    [J]. NEUROLOGY, 1996, 47 (04) : 1085 - 1087
  • [26] PSYCHOSIS IN PARKINSON'S DISEASE PATIENTS
    Rahman, Abdul Hamid Abdul
    Abu Samah, Ibrahim
    Saini, Suriati Mohamed
    [J]. ASEAN JOURNAL OF PSYCHIATRY, 2013, 14 (02): : 96 - 102
  • [27] Mental disorders in Parkinson's disease: Treatment with quetiapine
    Pacchetti, C
    Mancini, F
    Cristina, S
    Zangaglia, R
    Martignoni, E
    Nappi, G
    [J]. MOVEMENT DISORDERS, 2002, 17 : S121 - S121
  • [28] Systematic literature review of quetiapine for hallucinosis/psychosis in Parkinson's disease (PD).
    Chen, Jack J.
    Dashtipour, Khashayar
    Massihi, Lilian
    Tashiro, Stephanie
    Portillo, Ivan
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E300 - E301
  • [29] Safety and tolerability of Seroquel(R)(QUETIAPINE) in elderly subjects with psychosis
    McManus, DQ
    Rak, IW
    Arvanitis, LA
    [J]. NEUROLOGY, 1997, 48 (03) : 2027 - 2027
  • [30] Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease
    L. Morgante
    A. Epifanio
    E. Spina
    A.E. Di Rosa
    M. Zappia
    G. Basile
    P. La Spina
    A. Quattrone
    [J]. Neurological Sciences, 2002, 23 : s89 - s90
12345